首页> 外文期刊>Journal of bacteriology >Metabolism of Thymineless Mutants of Escherichia coli I. Absence of Thymidylate Synthetase Activity and Growth Characteristics of Two Sequential Thymineless Mutants
【24h】

Metabolism of Thymineless Mutants of Escherichia coli I. Absence of Thymidylate Synthetase Activity and Growth Characteristics of Two Sequential Thymineless Mutants

机译:大肠杆菌无胸腺突变体的代谢I.胸苷酸合成酶活性的缺失和两个连续无胸腺突变体的生长特性

获取原文

摘要

A study of optimal thymine and deoxythymidine (dThd) growth requirements of the thymineless mutants of Escherichia coli 15, E. coli 70–462 (strain 70), and a variant, E. coli 70V3–462 (strain 70V3), showed that for maximal turbidity (growth) strain 70 required 10-fold greater concentrations of thymine or dThd than did strain 70V3. On suboptimal concentrations of thymine or dThd, growth of strain 70 was greater on dThd than on thymine. In contrast, maximal growth of strain 70V3 was the same on equimolar concentrations of thymine and dThd. Growth rate of strain 70V3 was the same on equimolar concentrations of thymine and dThd up to 4 μm; at concentrations of 5 μm and greater, the “4-hr” growth was lower on dThd than on corresponding concentrations of thymine. Cultures of both thymineless mutants synthesized equal maximal amounts of DNA. Whereas strain 70V3 incorporated a maximum of 90% of the thymine or dThd in the media, strain 70 incorporated a maximum of only 10%. This poor utilization by strain 70 was neither a result of thymine or dThd conversion to a low-molecular-weight thymine derivative nor the production of a nonthymine inhibitory substance. Since strains 70 and 70V3 exhibited no thymidylate synthetase activity, the first mutation (strain 15 to strain 70) resulted in the loss of this activity. The second mutation (strain 70 to strain 70V3) probably brought about the loss of an enzyme(s) that catabolizes deoxyribose phosphate, permitting a greater net synthesis of dThd from thymine.
机译:大肠杆菌 15, E的无胸腺嘧啶突变体的最佳胸腺嘧啶和脱氧胸苷(dThd)生长需求的研究。大肠杆菌 70-462(菌株70)和变体 E。大肠杆菌70V3–462(菌株70V3)显示,对于最大的浊度(生长)菌株70,其胸腺嘧啶或dThd的浓度是70V3菌株的10倍。在胸腺嘧啶或dThd浓度不理想的情况下,菌株70在dThd上的生长大于在胸腺嘧啶上的生长。相反,在等摩尔浓度的胸腺嘧啶和dThd上,菌株70V3的最大生长相同。在胸腺嘧啶和dThd等摩尔浓度至4μm时,菌株70V3的生长速率相同;当浓度大于等于5μm时,dThd的“ 4-hr”生长要比相应浓度的胸腺嘧啶的低。两种无胸腺嘧啶突变体的培养物合成的DNA量相等。菌株70V3在培养基中最多掺入90%的胸腺嘧啶或dThd,而菌株70V3仅掺入最多10%的胸腺嘧啶或dThd。菌株70的这种不良利用既不是胸腺嘧啶或dThd转化为低分子量胸腺嘧啶衍生物的结果,也不是非胸腺嘧啶抑制物质的产生。由于菌株70和70V3不显示胸苷酸合成酶活性,因此第一个突变(菌株15至菌株70)导致该活性丧失。第二个突变(从70到70V3的菌株)可能导致分解脱氧核糖磷酸的酶的丢失,从而使胸腺嘧啶中dThd的净合成量更大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号